Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sonja Scholz MD, PhD

Sonja W. Scholz MD, PhD

Senior Investigator, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Adjunct Professor of Neurology, Johns Hopkins University, Baltimore, Maryland

Dr. Scholz is a physician-scientist specializing in neurodegeneration. She received her medical degree from the Medical University Innsbruck, Austria, and a Ph.D. in Neurogenomics from the University College London, UK. She completed a neurology residency training at Johns Hopkins University before joining the National Institutes of Health as a neurologist-scientist. She is a Senior Investigator at the National Institute of Neurological Disorders and Stroke and an Adjunct Professor of Neurology at Johns Hopkins University. Her primary area of research is the genetic characterization of atypical parkinsonism syndromes, such as Lewy body dementia, multiple system atrophy, and frontotemporal dementia. She specializes in applying modern genomic techniques and data-driven approaches to assess molecular genetic mechanisms implicated in these complex neurodegenerative disorders and identify targets suitable for disease-modifying therapeutic interventions.